Questa News
Aerin Announces New Funding to Further Fuel Growth
January 13, 2025
Contributors
No items found.
- Aerin Medical is a privately held, venture-backed medical device company headquartered in Mountain View, California, focused on expanding access to relief for patients suffering from chronic ENT conditions. Their products, VivAer for nasal airway obstruction and RhinAer for chronic rhinitis, use proprietary temperature-controlled technology that allows ENT physicians to improve patients' symptoms as alternatives to invasive surgery.
- In January 2025, Aerin Medical secured $32.5 million in new equity capital led by existing investors KCK MedTech, Questa Capital, OrbiMed, and Ally Bridge Group, with new participation from Ares Capital. Additionally, the company secured a debt facility from Ares Capital to refinance existing debt and provide more financial flexibility.
- "This additional funding significantly strengthens our financial position, supporting continued commercial expansion, along with investments in significant R&D and leading clinical evidence-generation that have been signatures of Aerin's progress," said Matt Brokaw, CEO of Aerin Medical.
- Read more here: https://aerinmedical.com/company/news-and-media/aerin-announces-new-funding-to-further-fuel-growth/
Working hand in hand with companies that transform healthcare is our privilege and responsibility.
.avif)